Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2012
05/03/2012US20120107244 MONOMERIC VARIANTS OF THE TETRAMERIC eqFP611
05/03/2012US20120107235 Alpha-Fetoprotein Immu31 Antibodies and Fusion Proteins and Methods of Use Thereof
05/03/2012US20120107234 Pan-HER Antibody Composition
05/03/2012DE102010043015A1 Verfahren zur Konzentration von Probenbestandteilen und Amplifikation von Nukleinsäuren A process for the concentration of sample components and amplification of nucleic acids
05/03/2012CA2853613A1 Hbv treatment
05/03/2012CA2819230A1 Methods and compositions for assessing and treating cancer
05/03/2012CA2819117A1 Anti-sod1 antibodies and uses thereof
05/03/2012CA2816321A1 Compositions and methods for inhibition of pcsk9 genes
05/03/2012CA2816306A1 Isoprene synthase variants for improved production of isoprene
05/03/2012CA2816291A1 Novel anti-dr5 antibody
05/03/2012CA2816281A1 A plant homolog to autophagy protein p62
05/03/2012CA2816060A1 Rapid salmonella serotyping assay
05/03/2012CA2816056A1 Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
05/03/2012CA2816050A1 Method for purifying human granulocyte-colony stimulating factor from recombinant e. coli
05/03/2012CA2815905A1 Temperature-stable .beta.-pyranosidase
05/03/2012CA2815888A1 Clostridium difficile-specific antibodies and uses thereof
05/03/2012CA2815829A1 Modified valencene synthase polypeptides, encoding nucleic acid molecules and uses thereof
05/03/2012CA2815769A1 Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
05/03/2012CA2815277A1 Novel egfr-binding molecules and immunoconjugates thereof
05/03/2012CA2815222A1 Cell fate conversion of differentiated somatic cells into glial cells
05/03/2012CA2815116A1 Down-regulating gene expression in insect pests
05/03/2012CA2815112A1 Murine model of inflammation with il33 n-terminal domain deletion
05/03/2012CA2815096A1 Overexpression of plant mirnas for parasite control
05/03/2012CA2814552A1 Luminophore-labeled molecules coupled with particles for microarray-based assays
05/03/2012CA2814187A1 Drought tolerant plants and related constructs and methods involving genes encoding dtp6 polypeptides
05/03/2012CA2795577A1 New compositions and methods for treatment of autoimmune and allergic diseases
05/02/2012EP2447374A2 In vitro method for the prognosis or prediction of the response in patients with rheumatoid arthritis treated with agents that recognize the cd20 membrane receptor in b lymphocytes
05/02/2012EP2447371A1 Plant promoters, terminators, genes, vectors and related transformed plants
05/02/2012EP2447370A1 MicroRNA molecules
05/02/2012EP2447369A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447368A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447367A2 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
05/02/2012EP2447366A1 Method of synthesizing single-stranded cDNA, method of preparing microarray sample, and method of detecting nucleic acid
05/02/2012EP2447365A1 Cell-free protein synthesis solution, cell-free protein synthesis kit, and protein synthesis method
05/02/2012EP2447364A1 Modified biotin-conjugated protein
05/02/2012EP2447362A2 Alkaline cellulase variants
05/02/2012EP2447360A1 Gene defects and mutant ALK kinase in human solid tumors
05/02/2012EP2447359A1 Gene defects and mutant ALK kinase in human solid tumors
05/02/2012EP2447283A2 Human monoclonal antibodies to activin receptor-like kinase-1 (ALK-1)
05/02/2012EP2447281A1 Novel anti-PLGF antibody
05/02/2012EP2447279A1 Methods and compositions for gene inactivation
05/02/2012EP2447278A1 Novel immunogenic proteins of Leptospira
05/02/2012EP2446896A1 Activin-ActRII Antagonists for use in Increasing Red Blood Cells, increasing reticulocyte levels, or promoting erythropoiesis
05/02/2012EP2446890A1 High viscosity macromolecular compositions for treating ocular conditions
05/02/2012EP2446886A1 Autophagy regulators and the uses thereof in the treatment of collagen VI defective Muscular Dystrophies
05/02/2012EP2446054A1 Process for amplifying dna using tetraethylene glycol, kit of parts therefor and use thereof
05/02/2012EP2446041A1 Biosynthesis of 1-alkenes in engineered microorganisms
05/02/2012EP2446040A1 Methods for agrobacterium-mediated transformation of sugar cane
05/02/2012EP2446039A1 Method for fermentatively preparing l-amino acids
05/02/2012EP2446037A2 Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
05/02/2012EP2446036A2 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
05/02/2012EP2446035A1 Novel drugs for inhibition of gene expression
05/02/2012EP2446034A1 Novel polynucleotide molecules for enhanced gene expression
05/02/2012EP2446033A2 Method of preparing an adduct
05/02/2012EP2446032A1 Expression of surrogate light chains
05/02/2012EP2446031A1 Stabilizing alkylglycoside compositions and methods thereof
05/02/2012EP2446030A1 Synthetic operon
05/02/2012EP2446027A1 Protein
05/02/2012EP2446025A2 Ketoreductase-mediated stereoselective route to alpha chloroalcohols
05/02/2012EP2446023A2 Adult animals generated from induced pluripotent cells
05/02/2012EP2446020A1 Dental stem cell reprogramming
05/02/2012EP2446019A2 Recombinant ethanologenic bacteria
05/02/2012EP2445930A1 Bacterial expression of an artificial gene for the production of crm197 and its derivatives
05/02/2012EP2445929A1 A method for transforming a bacterium belonging to the streptococcus genus by natural competence
05/02/2012EP2445928A1 Chimeric influenza virus-like particles comprising hemagglutinin
05/02/2012EP2445927A1 Lipidated tumor- associated antigens and immunotherapeutic compositions
05/02/2012EP2445334A1 Non human animal models for increased retinal vascular permeability
05/02/2012EP2089528B1 A method for producing an l-amino acid using a bacterium of the genus escherichia with attenuated expression of any of the cynt, cyns, cynx or cynr genes or a combination thereof
05/02/2012EP1804835B9 Multimeric constructs
05/02/2012EP1664315B1 Aav vectors for in vivo gene therapy of rheumatoid arthritis
05/02/2012EP1637881B1 Sample arraying/assembling device, its method, and apparatus using sample assembly
05/02/2012EP1634951B1 Novel protein
05/02/2012EP1633875B1 Wheat plants having increased tolerance to imidazolinone herbicides
05/02/2012EP1389130B1 Use of osteopontin for the treatment and/or prevention of neurologic diseases
05/02/2012EP1343822B1 Means for the diagnosis and therapy of ctcl
05/02/2012EP1256348B1 Remedies for hepatitis c
05/02/2012CN1902315B Endoglucanase STCE and cellulase preparation containing the same
05/02/2012CN1231673B Polynucleotide and its use for modulating a defence response in plants
05/02/2012CN102439447A Method for detecting substance in biological sample
05/02/2012CN102439444A Measuring g protein coupled receptor activation
05/02/2012CN102439176A Phosphodiesterase 4d7 as marker for malignant, hormone-sensitive prostate cancer
05/02/2012CN102439174A Compositions and methods for diagnosing prostate cancer based on detection of slc45a3-elk4 fusion transcript
05/02/2012CN102439158A Highly acidic chitosan-nucleic acid polyplex compositions
05/02/2012CN102439157A Compositions for targeting conducting airway cells comprising adeno-associated virus constructs
05/02/2012CN102439156A Bidirectional promoter from z. mais
05/02/2012CN102439155A Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites
05/02/2012CN102439154A A polynucleotide and polypeptide sequence and methods thereof
05/02/2012CN102439153A Compositions for stimulation of mammalian innate immune resistance to pathogens
05/02/2012CN102439152A Rna interference mediated inhibition of the intercellular adhesion molecule 1 (icam-1)gene expression using short interfering nucleic acid (sina)
05/02/2012CN102439151A Rna interference mediated inhibition of btb and cnc homology 1, basic leucine zipper transcription factor 1 (bach 1) gene expression using short interfering nucleic acid (sina) sequence listing
05/02/2012CN102439150A Kanamycin antisense nucleic acid for the treatment of cancer
05/02/2012CN102439149A Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
05/02/2012CN102439148A Sirna conjugate and preparation method thereof
05/02/2012CN102439147A Vangl1 peptides and vaccines including the same
05/02/2012CN102439145A Carbohydrate degrading polypeptide and uses thereof
05/02/2012CN102439143A Method of producing a lipolytic enzyme
05/02/2012CN102439140A Chinese hamster ovary cell lines
05/02/2012CN102439136A Mesenchymal stem cells producing inhibitory rna for disease modification
05/02/2012CN102439134A Tuberculosis vaccines including recombinant bcg strains overexpressing phop, and/or phop regulon protein(s)
05/02/2012CN102439045A Establishment of induced pluripotent stem cell using cell-permeable reprogramming transcription factor for customized stem cell therapy